TLR4 and diabetes mellitus: We also demonstrated the anti-inflammatory effect ATRA by suppressing the toll-like receptor 4 (TLR4) and the nuclear factor-кB (NF-кB) signaling in glomeruli and proximal tubules in a model of diabetes [18,19].